Pulse Biosciences (PLSE) Raw Materials (2021 - 2022)

Pulse Biosciences' (PLSE) quarterly Raw Materials came in at $3.5 million in Q2 2022, up 13.8% quarter-over-quarter from $3.1 million in Q1 2022.

Pulse Biosciences (PLSE) Raw Materials (2021 - 2022) Analysis & Trends

Pulse Biosciences' Raw Materials history runs 2 years deep, the most recent figure standing at $3.5 million for Q2 2022.

On a quarterly basis, Raw Materials changed N/A year-over-year to $3.5 million in Q2 2022; TTM through Jun 2022 was $3.5 million, a N/A change from a year earlier, with the FY2021 full-year figure at $2.0 million, changed N/A from the prior year.
Raw Materials grew to $3.5 million in Q2 2022 per PLSE's latest filing, from $3.1 million in the prior quarter.
Across five years, Raw Materials topped out at $3.5 million in Q2 2022 and bottomed at $1.4 million in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn
10	Pulse Biosciences	2.09 Bn	2.01 Bn	-

Download Data